Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data

INTRODUCTION: People with cystic fibrosis (CF) are often on multiple long-term treatments, including mucoactive nebulisers. In the UK, the most common mucoactive nebuliser is dornase alfa (DNase). A common therapeutic approach for people already on DNase is to add hypertonic saline (HS). The effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Granger, Emily, Davies, Gwyneth, Keogh, Ruth H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Cystic Fibrosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511967/
https://www.ncbi.nlm.nih.gov/pubmed/37451864
http://dx.doi.org/10.1136/thorax-2023-220031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511967/
https://www.ncbi.nlm.nih.gov/pubmed/37451864
http://dx.doi.org/10.1136/thorax-2023-220031

Ejemplares similares